TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 26 filers reported holding TRINITY BIOTECH PLC in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $31,000 | +14.8% | 14,000 | +18.4% | 0.00% | 0.0% |
| Q4 2018 | $27,000 | -58.5% | 11,820 | -27.4% | 0.00% | -57.1% |
| Q3 2018 | $65,000 | -21.7% | 16,270 | -2.1% | 0.01% | -30.0% |
| Q2 2018 | $83,000 | -10.8% | 16,620 | -7.7% | 0.01% | -16.7% |
| Q1 2018 | $93,000 | -24.4% | 18,000 | -25.3% | 0.01% | -20.0% |
| Q4 2017 | $123,000 | -21.2% | 24,100 | -13.5% | 0.02% | -25.0% |
| Q3 2017 | $156,000 | -8.2% | 27,850 | -1.6% | 0.02% | -9.1% |
| Q2 2017 | $170,000 | -2.9% | 28,300 | -3.6% | 0.02% | -8.3% |
| Q1 2017 | $175,000 | +92.3% | 29,350 | +122.3% | 0.02% | +84.6% |
| Q4 2016 | $91,000 | – | 13,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |